iGATE Research

Page 1 of 13

www.igateresearch.com

Global Cancer Vaccines Market - Overview

The cancer industry is one of the most lucrative business worldwide. Cancer vaccines are a viable
option for treating many types of cancers which in the present day do not have effective
treatments. Cancer vaccines can be broadly classified into two segments: prophylactic and
therapeutic vaccines. Prophylactic vaccines are used for the prevention of cancer, whereas
therapeutic vaccines are used for treatment of cancer. With the rising incidences of cancer and
limited treatment options, physicians are being forced to look for precautionary vaccines beyond
the conventional treatments. As a result, many companies are now investing in developing
prophylactic and therapeutic vaccines to curb this deadly disease.
The prophylactic vaccines currently available in the market include Merck's Gardasil and GSK's
Cervarix while the only therapeutic vaccine in the market is Dendreon's Provenge. In the global
cancer vaccines market, the prophylactic vaccines segment account for maximum share of the
market. However, the market share of prophylactic vaccines is likely to decline continuously
during the forecasting period due to the increasing uptake of therapeutic vaccines. The market
share of therapeutic cancer vaccines is anticipated to increase during the forecasting period.
In the cancer vaccines market, Merck is the clear leader and is expected to maintain its
dominancy over a longer period of time. Dendreon Corporation is the second leading player in
Cancer vaccines market accounting for XX% market share in 2014. It is predicted that GSK will
account for single digit share of the cancer vaccine market by 2020.
Global Cancer Vaccines Market - Regional Analysis: The United States is the largest regional
market for cancer vaccines. United States accounted for XX% share of the global cancer vaccines
market in 2014. The Asian region is the second leading market for cancer vaccines. The European
region cancer vaccines market share is anticipated to increase from XX% in 2014 to XX% by the
year 2020.
iGATE Research report titled Global - Cancer Vaccines Market and Pipeline Vaccines Analysis
to 2020 is a 213 page report with 26 Figures and 25 Tables. This report analyses the Global
Cancer Vaccines Market, Regional Cancer Vaccines Market, Major Deals and Funding in Cancer

iGATE Research

Page 2 of 13

www.igateresearch.com

Vaccines Industry, Cancer Vaccines Pipeline Products Portfolio, Company Wise Cancer Vaccines
Pipeline Products and the driving factors and challenges for the Cancer Vaccines Market.

The Cancer Vaccines Market studied in the report covers the following 7 points:
1. Global - Prophylactic Cancer Vaccines Market to 2020

Gardasil

Cervarix

2. Global - Therapeutic Cancer Vaccines Market to 2020

Provenge

3. Cancer Vaccines Market - Regional Analysis to 2020

United States - Cancer Vaccines Market

Europe - Cancer Vaccines Market

Asia - Cancer Vaccines Market

4. Global Cancer Vaccines Market - Major Deals

5. Global Cancer Vaccines - Funding
6. Global Cancer Vaccines Market - Pipeline Portfolio Analysis
7. Company Cancer Vaccines - Pipeline Analysis
The 12 Cancer Vaccines Pipeline Portfolio covered in the report are as follows
1. Prostvac
2. Neuvax
3. Rindopepimut
4. MVax
5. DCVax-L
6. ProstAtak

iGATE Research

Page 3 of 13

www.igateresearch.com

7. Talimogene Laherparepvec
8. IMA901
9. Imprime PGG
10. OncoVAX
11. Lucanix
12. DCVAC/PCa
The 34 Companies Pipeline Cancer Vaccines covered in the reports are as follows:
1. Aduro Biotech
2. Advantagene
3. Advaxis
4. Agenus
5. AlphaVax
6. Altor BioScience
7. Argos Therapeutics
8. AVAX Technologies
9. Bavarian Nordic
10. Biothera
11. Celldex Therapeutics
12. CureVac
13. Galena Biopharma
14. Genexine
15. GlobeImmune
16. Gradalis
17. Heat Biologics
18. Immatics
19. ImmunoCellular Therapeutics
20. Inovio Pharmaceuticals
21. ISA Pharmaceuticals
22. Juvaris Biotherapeutics
23. NewLink Genetics
24. Northwest Biotherapeutics

iGATE Research

Page 4 of 13

www.igateresearch.com

25. NovaRx
26. OncoThyreon
27. Oncovir
28. Oxford BioMedica
29. Prima BioMed
30. Sotio
31. Transgene
32. Ubivac
33. Vaccinogen
34. Vaxon Biotech

iGATE Research

Page 5 of 13

www.igateresearch.com

Table of Contents
1.

Executive Summary

2.

Global - Cancer Vaccines Market and Forecast to 2020

3.

4.

5.

2.1

Global - Prophylactic Cancer Vaccines Market and Forecast to 2020

2.2

Global - Therapeutic Cancer Vaccines Market and Forecast to 2020

Global - Cancer Vaccines Market Share and Forecast to 2020

3.1

Global Cancer Vaccines Market Share - By Type

3.2

Global Cancer Vaccines Market - Company Share Analysis

3.3

Cancer Vaccines Market - Regional Share Analysis

Global - Prophylactic Cancer Vaccines Market and Forecast to 2020

4.1

Gardasil Sales and Forecast to 2020

4.2

Cervarix Sales and Forecast to 2020

Global - Therapeutics Cancer Vaccines Market and Forecast to 2020

5.1

6.

Provenge Sales and Forecast to 2020

Cancer Vaccines Market - Regional Analysis

6.1

United States - Cancer Vaccines Market and Forecast to 2020

6.2

Europe - Cancer Vaccines Market and Forecast to 2020

6.3

Asia - Cancer Vaccines Market and Forecast to 2020

7.

Global Cancer Vaccines Market - Major Deals

8.

Global Cancer Vaccines - Funding

9.

Global Cancer Vaccines Market - Pipeline Portfolio Analysis

9.1

Prostvac

9.2

Neuvax

9.3

Rindopepimut

9.4

MVax

9.5

DCVax-L

iGATE Research

Page 6 of 13

www.igateresearch.com

9.6

ProstAtak

9.7

Talimogene Laherparepvec

9.8

IMA901

9.9

Imprime PGG

9.10

OncoVAX

9.11

Lucanix

9.12

DCVAC/PCa

10.

Company Cancer Vaccines - Pipeline Analysis

10.1

Aduro Biotech

10.2

Advantagene

10.3

Advaxis

10.4

Agenus

10.5

AlphaVax

10.6

Altor BioScience

10.7

Argos Therapeutics

10.8

AVAX Technologies

10.9

Bavarian Nordic

10.10

Biothera

10.11

Celldex Therapeutics

10.12

CureVac

10.13

Galena Biopharma

10.14

Genexine

10.15

GlobeImmune

10.16

Gradalis

10.17

Heat Biologics

10.18

Immatics

10.19

ImmunoCellular Therapeutics

iGATE Research

Page 7 of 13

www.igateresearch.com

10.20

Inovio Pharmaceuticals

10.21

ISA Pharmaceuticals

10.22

Juvaris Biotherapeutics

10.23

NewLink Genetics

10.24

Northwest Biotherapeutics

10.25

NovaRx

10.26

OncoThyreon

10.27

Oncovir

10.28

Oxford BioMedica

10.29

Prima BioMed

10.30

Sotio

10.31

Transgene

10.32

Ubivac

10.33

Vaccinogen

10.34

Vaxon Biotech

11.

Global Cancer Vaccines Market - Driving Factors

11.1

Increasing Incidence of Cancer

11.2

GAVI Model Fuelling Vaccine Manufacturers

11.2.1

The Partnership Model

11.2.2

The Business Model

11.3

Global Immunization Vision and Strategy (GIVS)

11.4

Growing Vaccine Availability in United States

11.5

The Vaccine Injury Compensation Program

11.6

The Vaccine Safety Data link Project

11.7

Transformation of Vaccine Technologies

11.8

Global Vaccine Action Plan by WHO (2011 - 2020)

11.9

Continuous Focus on Effective Communication Strategies

12.

Global Cancer Vaccines Market - Challenges

iGATE Research

Page 8 of 13

www.igateresearch.com

12.1

Hurdles to Optimal use of Licensed Vaccines

12.1.1

Technical Obstacles

12.1.2

Economic obstacles

12.1.3

Cultural Obstacles

12.2

Shortening the Timeline for Vaccine Development

12.3

Complexity of Vaccine Development and Approval System Thwarts Product Development

12.3.1

Legal Obstacles

12.3.2

General Technical Barriers

12.3.3

Economic Barriers

12.3.4

Regulatory Barriers

12.4

Obstacles in Vaccine Research and Development

12.5

Barriers to New Entrants in the Vaccines Market

iGATE Research

Page 9 of 13

www.igateresearch.com

List of Figures:

Figure 2-1: Global - Cancer Vaccines Market (Million US$), 2007 - 2014
Figure 2-2: Global - Forecast for Cancer Vaccines Market (Million US$), 2015 - 2020
Figure 2-3: Global - Prophylactic Cancer Vaccines Market (Million US$), 2007 - 2014
Figure 2-4: Global - Forecast for Prophylactic Cancer Vaccines Market (Million US$), 2015 - 2020
Figure 2-5: Global - Therapeutic Cancer Vaccines Market (Million US$), 2011 - 2014
Figure 2-6: Global - Forecast for Therapeutic Cancer Vaccines Market (Million US$), 2015 - 2020
Figure 3-1: Global - Cancer Vaccines Market Share (Percent), 2011 - 2014
Figure 3-2: Global - Forecast for Cancer Vaccines Market Share (Percent), 2015 - 2020
Figure 3-3: By Company - Cancer Vaccines Market Share (Percent), 2011 - 2014
Figure 3-4: By Company - Forecast for Cancer Vaccines Market Share (Percent), 2015 - 2020
Figure 3-5: By Region - Cancer Vaccines Market Share (Percent), 2010 - 2014
Figure 3-6: By Region - Forecast for Cancer Vaccines Market Share (Percent), 2015 - 2020
Figure 4-1: Global - Gardasil Vaccines Sales (Million US$), 2007 - 2014
Figure 4-2: Global - Forecast for Gardasil Vaccines Sales (Million US$), 2015 - 2020
Figure 4-3: Global - Cervarix Vaccines Sales (Million US$), 2007 - 2014
Figure 4-4: Global - Forecast for Cervarix Vaccines Sales (Million US$), 2015 - 2020
Figure 5-1: Global - Provenge Vaccines Sales (Million US$), 2011 - 2014
Figure 5-2: Global - Forecast for Provenge Vaccines Sales (Million US$), 2015 - 2020
Figure 6-1: United States - Cancer Vaccines Market (Million US$), 2010 - 2014
Figure 6-2: United States - Forecast for Cancer Vaccines Market (Million US$), 2015 - 2020
Figure 6-3: Europe - Cancer Vaccines Market (Million US$), 2010 - 2014
Figure 6-4: Europe - Forecast for Cancer Vaccines Market (Million US$), 2015 - 2020
Figure 6-5: Asia - Cancer Vaccines Market (Million US$), 2010 - 2014
Figure 6-6: Asia - Forecast for Cancer Vaccines Market (Million US$), 2015 - 2020
Figure 11-1: Global - Estimated Number of Cancer Incidence Cases (Number), 2009 - 2015
Figure 11-2: US - Number of Retail Clinics offering Vaccination (Number), 2007 - 2012

iGATE Research

Page 10 of 13

www.igateresearch.com

List of Tables:

Table 9-1: NovaRx - Clinical Development Pipeline

Table 10-1: AlphaVax - Clinical Development Pipeline
Table 10-2: Altor BioScience - Clinical Development Pipeline
Table 10-3: Argos Therapeutics - Clinical Development Pipeline
Table 10-4: AVAX Technologies - Clinical Development Pipeline
Table 10-5: Biothera - Clinical Development Pipeline
Table 10-6: Celldex Therapeutics - Clinical Development Pipeline
Table 10-7: CureVac - Clinical Development Pipeline
Table 10-8: Genexine - Clinical Development Pipeline
Table 10-9: GlobeImmune - Clinical Development Pipeline
Table 10-10: Gradalis - Clinical Development Pipeline
Table 10-11: Heat Biologics - Clinical Development Pipeline
Table 10-12: ISA Pharmaceuticals - Clinical Development Pipeline
Table 10-13: ISA101-CervISA - Clinical Study Analysis
Table 10-14: NewLink Genetics - Clinical Development Pipeline
Table 10-15: Northwest Biotherapeutics - Clinical Development Pipeline
Table 10-16: NovaRx - Clinical Development Pipeline
Table 10-17: Sotio - Clinical Development Pipeline
Table 10-18: Transgene - Clinical Development Pipeline
Table 10-19: UbiVac - Clinical Development Pipeline
Table 10-20: Vaccinogen - ACTIVE Clinical Trial Analysis
Table 10-21: Vaxon Biotech - Clinical Developmet Pipeline
Table 11-1: Global - Total Future Deaths Averted through Vaccination (Million), 2011 - 2020
Table 11-2: Global Goal-Level Indicators, 2015 & 2020
Table 11-3: Improvement Strategies or Requirements - the Joint Commission and the Projects Collaborating
Organizations

iGATE Research

Page 11 of 13

www.igateresearch.com

Order the Report

Report Title: Global - Cancer Vaccines Market and Pipeline Vaccines Analysis to 2020
To Order the Report Visit:
http://www.igateresearch.com/ProductDetail.php?pd_name=Global%20%20Cancer%20Vaccines%20Market%20and%20Pipeline%20Vaccines%20Analysis%20to%202020

Single User License

US$ 1,290

Hard-copy Mail Delivery

US$ 1,450

CD-ROM Mail Delivery

US$ 1,400

Multi User License

US$ 1,800

For More Details, Visit:

http://www.igateresearch.com/

iGATE Research

Page 12 of 13

www.igateresearch.com

Contact US
iGATE RESEARCH PVT. LTD.
Web: www.igateresearch.com
To order the Report:
E-Mail: info@igateresearch.com
Contact No: +91-858-684-0791, +91-971-801-4310 (INDIA)
For Report Related Query:
E-Mail: ravi.sinha@igateresearch.com
Contact: +91-858-684-0791, +91-706-527-9335 (INDIA)

Follow US

Facebook: https://web.facebook.com/IGATE-Research-661335464008243/?ref=tn_tnmn
Twitter: https://twitter.com/IgateResearch
You Tube: https://www.youtube.com/channel/UCOr7KNn4JfTwk5_kQjj-xrQ
Google+: https://plus.google.com/110560526954506242845/posts
LinkedIn: https://www.linkedin.com/company/igate-research

iGATE Research

Page 13 of 13

www.igateresearch.com